TABITHA PALOIAN: Open Payments
NPI 1275111684 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 71 payments from 20 companies in 2025. Trend: 2023 $1,328 · 2024 $1,126 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $327 |
| Novo Nordisk Inc | 15 | $179 |
| ABBVIE INC. | 10 | $149 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $132 |
| Astellas Pharma US Inc | 4 | $92 |
| Lilly USA, LLC | 4 | $65 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| Amgen Inc. | 2 | $31 |
| Exact Sciences Corporation | 2 | $30 |
Products named: BREZTRI, Ozempic, LifeVest, VRAYLAR, Veozah, MOUNJARO, FARXIGA, Auvelity.
Industry payments across TN — which companies pay providers there.
